- Categories:ABOUT US
- Time of issue:2018-02-07 00:00:00
Jiangsu Qianmu Biotechnology Co., Ltd., founded in 2009 with a registered capital of 50.48 million Yuan, is a comprehensive production enterprise that specializes in the purchase, processing and sale of prepared intestine and the production of bulk drug, calciparine, sodium chondroitin sulfate, chondroitin sulfate (for injection), Nadroparin Calcium, Enoxaparin Sodium, and Dalteparin Sodium. It also engages in the research and development of biotechnology and the production and sale of biological products.
Based on the business principle of “driven by science and technology and survival by quality” and with the care and support of the local government and the competent quarantine inspection organ, our company has established sound, stable and long-term partnership with many famous brands at home and abroad. At the same time, Qianmu has set up sales network in Southeast Asia, Far East and other regions.
Prepared intestine: It can be divided into natural casings (pickled prepared intestine), dry prepared intestine sleeve, collagen prepared intestine, etc.
Main purpose: make various sausage, such as Taiwan hotdog, sausage, Harbin bologna sausage, Rugao sausage, and Taiwan sticky rice sausage.
Heparin: Heparin is a polyoses biochemical substance as extracted from the mucous membrane of small intestine of pigs. Our heparin extraction technology has been taking the lead in China and we have entered into cooperation with many a medicine enterprise in China. Its main purposes include reducing blood fat, and therefore it can be applied to cardiovascular drug, anti-blood agent, etc. Moreover, it can cure the early stage of disseminated intravascular coagulation (DIC) intercurrent from various diseases and prevent arterial and venous thrombus, pulmonary embolism, etc. Presently our company has been developing high-quality heparin. Related products are characterized by little impact on blood cells, long half-life period, and high degree of biological availability. In the future, Qianmu will carry out deep research and development in injection and medicinal extract as well as volume production.
So far our company has obtained 26 patents. Qianmu was rated as leading enterprise in agriculture in Nantong in 2013 and became member of Jiangsu Agriculture Association in 2015. In 2016, Qianmu obtained the HACCP and ISO 22000 quality management system certification. In 2017, our company won the AAA enterprise credit certificate. In the same year, Qianmy was rated as enterprise in Nantong that abides by contract and stresses credit.
Scan the QR code to read on your phone